… In this study, we evaluated risk factors for dry eye disease, intraocular pressure, and …
bronchodilators or corticosteroids via nebulizer but not inhaler is related to greater rates of dry eye. …

… It is advisable that an ophthalmologist consultation is sought for patients deemed to be at
risk for AACG before initiating on bronchodilator therapy. This may be feasible in selected …

… Inhaled and nasal glucocorticoids and the risks of ocular … The effect of nebulized
bronchodilator therapy on intraocular … Ocular hazards of nebulized bronchodilators. Postgrad Med …

… This study aimed to determine the reported risk of glaucoma, ocular hypertension (OHT) …
that assess ocular outcomes related to glaucoma in ICS and INS users. Study selection, risk of …

… given in the clinical setting are bronchodilators.12 … of nebulized bronchodilator therapy
over handheld devices in patients who can use them properly.2 Due to equivalence, nebulized …

… Both systemic and inhaled corticosteroids may increase the risk … corticosteroid exposure
and the risk of cataract development. … Pooled analyses revealed on average a doubled risk of …

… higher-dose combination group than in the albuterol-alone group (hazard ratio, 0.74; 95% …
A fixed-dose combination of inhaled albuterol and budesonide, as compared with albuterol …

… Oral or inhaled bronchodilators and systemic steroid were similarly used in both groups …
according to the visual sum score in bronchiectasis on chest CT and the risk of pneumonia. …

… Common anatomical risk factors for AACG include a shallow … However, there is a report of
exposure to nebulized albuterol … eye can be avoided with the use of goggles during nebulizer …

… Publication bias was assessed qualitatively by visual inspection of the funnel plot and … [6]
reported that inhaled LAMA significantly increased the risk of MACE by 58% in COPD …